<DOC>
	<DOCNO>NCT02915094</DOCNO>
	<brief_summary>Objective study gain knowledge administration Kineret patient rheumatoid arthritis daily routine treatment control trial . In current survey , investigation response rate Kineret regard date onset action , efficacy , well tolerability safety particular interest .</brief_summary>
	<brief_title>Kineret Treatment Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<criteria>Informed consent patient Rheumatoid arthritis Previous methotrexate therapy inadequate response Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>